Sanjeev K. Neela
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection.
Journal: JCI insight
Published: June 21, 2021
Correction: IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis.
Journal: PLoS pathogens
Published: May 06, 2021
Defective Antigen Presentation Leads to Upregulation of PD1 and IL-10 in HIV-TB Co-Infection.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: May 28, 2020
IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis.
Journal: PLoS pathogens
Published: April 07, 2019
Transforming Growth Factor-β Suppresses Interleukin (IL)-2 and IL-1β Production in HIV-Tuberculosis Co-Infection.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: April 03, 2019
Association of increased risk of asthma with elevated arginase & interleukin-13 levels in serum & rs2781666 G/T genotype of arginase I.
Journal: The Indian journal of medical research
Published: November 02, 2018
IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis.
Journal: BMC infectious diseases
Published: August 02, 2017
Mycobacterial r32-kDa antigen-specific T-cell responses correlate with successful treatment and a heightened anti-microbial response in human leprosy patients.
Journal: International immunology
Published: December 17, 2015
Last Updated: 09/26/2026